American Journal of Clinical Nutrition, Vol 46, 1029-1034, Copyright © 1987 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

High-dose carbonyl iron for iron deficiency anemia: a randomized double- blind trial

VR Gordeuk, GM Brittenham, M Hughes, LJ Keating and JJ Opplt
Department of Medicine, Cleveland Metropolitan General Hospital, OH 44109.

To determine if high doses of oral iron could shorten the duration of therapy necessary to treat Fe deficiency anemia, high-dose Fe 600 mg three times per day (given as nontoxic carbonyl Fe) was compared with standard ferrous sulfate 60 mg Fe++ three times per day in a randomized, double-blind, 3-wk trial involving 36 female blood donors with mild Fe deficiency anemia. In animal studies, both forms of Fe have similar bioavailability when administered in equal amounts. High- dose carbonyl Fe was well tolerated with gastrointestinal side effects similar those observed with standard FeSO4 therapy. The 10-fold larger amount of Fe resulted in a mean 1.5-fold increase in estimated Fe absorption. Both regimens corrected anemia but neither replenished storage Fe. These results suggest that the principal advantage to the use of carbonyl Fe would derive from its safety rather than from the large doses that can be given.

This article has been cited by other articles:

				J. H. Swain, L. K. Johnson, and J. R. Hunt Electrolytic Iron or Ferrous Sulfate Increase Body Iron in Women with Moderate to Low Iron Stores J. Nutr., March 1, 2007; 137(3): 620 - 627. [Abstract] [Full Text] [PDF]

				G. M. Brittenham, H. G. Klein, J. P. Kushner, and R. S. Ajioka Preserving the National Blood Supply Hematology, January 1, 2001; 2001(1): 422 - 432. [Abstract] [Full Text] [PDF]